Old Web
English
Sign In
Acemap
>
authorDetail
>
Gerald P. Miletello
Gerald P. Miletello
Internal medicine
Interleukin 2
Oncology
Medicine
Patient registry
2
Papers
8
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2.
2021
Journal of Investigative Medicine
Joseph I. Clark
Brendan Curti
Elizabeth J. Davis
Howard L. Kaufman
Asim Amin
Ajjai Alva
Theodore F. Logan
Ralph J. Hauke
Gerald P. Miletello
Ulka N. Vaishampayan
Douglas B. Johnson
Richard L. White
Peter H. Wiernik
Janice P. Dutcher
Show All
Source
Cite
Save
Citations (2)
Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIM
2019
Mayer Fishman
Janice P. Dutcher
Joseph I. Clark
A. álva
Gerald P. Miletello
Brendan D. Curti
Neeraj Agarwal
Ralph J. Hauke
Kathleen M. Mahoney
Helen Moon
Jonathan S. Treisman
Scott S. Tykodi
Gregory A. Daniels
Michael A. Morse
M. Wong
Howard L. Kaufman
Nancy C. Gregory
David F. McDermott
Show All
Source
Cite
Save
Citations (6)
1